CareDx Inks Supply Agreement with Illumina | GenomeWeb

NEW YORK (GenomeWeb) – Transplant molecular diagnostics company CareDx today announced a supply agreement with Illumina for next-generation sequencing technologies.

Under the terms of the multiyear deal, CareDx's reference and R&D laboratories will have access to Illumina's NGS, microarray equipment, and consumables. Financial and other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.